Transplant Diagnostics Market Size Worth $895.2 Million by 2024: Grand View Research, Inc.

Thursday, August 16, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, August 16, 2018 /PRNewswire/ --

The global transplant diagnostics market size is expected

to reach USD 895.2 million by 2024, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 7.6% over the forecast period. Increasing number of patients suffering from chronic diseases
frequently leading to organ failure is creating an upsurge in demand for transplant procedures. In addition, adoption of stem cell therapy and personalized medicine is escalating, thereby influencing demand for transplant diagnostics.

     (Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )

Risks and complexities associated with organ transplants necessitate the need for improved and sophisticated diagnostic tools. Next-Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to growing demand for high-throughput diagnostic tools with enhanced accuracy.

Market growth is expected to be restrained by factors such as reimbursement controversies and ethical issues in some parts of the world. In addition, high cost of performing HLA matching using Polymerase Chain Reaction (PCR) and NGS devices is challenging the growth of the transplant diagnostics market in developing countries.

Browse full research report with TOC on "Transplant Diagnostics Market Size, Share & Trends Analysis Report By Technology (Molecular Assays, Non-Molecular Assays), By Product (Reagents & Consumables, Instruments), And Segment Forecasts, 2018 - 2024" at: https://www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market

Further Key Findings From the Report Suggest: 

  • PCR-based molecular assay captured the largest share in the overall market in 2016 due to extensive adoption in HLA typing
  • The sequencing-based typing segment is anticipated to witness significant growth from 2016 to 2024. High adoption of NGS is a major factor driving segment growth
  • In 2016, the reagents and consumables segment accounted for the largest market share attributed to repeat purchase
  • North America captured the largest revenue share in 2016 and is expected to maintain its dominance throughout the forecast period due to well-established research infrastructure, increasing healthcare expenditure, high adoption of advanced diagnostic techniques, and growing R&D activities
  • Asia Pacific is expected to witness significant growth during the forecast period owing to expanding research opportunities, healthcare expenditure, medical tourism industry, and awareness regarding organ donation
  • Some major players in this market are Thermo Fisher Scientific, Inc.; Illumina, Inc.; F.Hoffmann La-Roche AG.; Abbott Laboratories, Inc.; Qiagen N.V.; Immucor Transplant Diagnostics, Inc.; Bio-Rad Laboratories, Inc.; Affymetrix, Inc.; and Omixon Ltd.

Browse related reports by Grand View Research: 

  • Robotic Prosthetics Market - The global robotic prosthetics market size was estimated at USD 790.8 million in 2016. 
  • Gamma Knife Market - The global gamma knife market size was valued at USD 171.5 million in 2016. 
  • Infectious Disease Therapeutics Market - The global infectious disease therapeutics market size was valued at USD 46.88 billion in 2016 and is projected to grow at a CAGR of 6.6% during the forecast period.
  • Pulmonary Drug Delivery Devices/Systems Market - The global pulmonary drug delivery devices/systems market size was estimated at USD 36.5 billion in 2016 and is expected to grow at a CAGR of 4.7% over the forecast period.

Grand View Research has segmented the global transplant diagnostics market on the basis of technology, product, and region: 

Transplant Diagnostics Technology Type Outlook (Revenue, USD Million, 2014 - 2024) 

  • Molecular Assay
    • PCR-based Molecular Assay
    • Sequencing-based Molecular Assay
  • Non-molecular Assay
    • Serological Assay
    • Mixed Lymphocyte Culture Assay

Transplant Diagnostics Product Type Outlook (Revenue, USD Million, 2014 - 2024) 

  • Reagents & Consumables
  • Instruments
  • Software and Services

Transplant Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2024) 

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific
    • Japan
    • India
  • Latin America
    • Mexico
    • Brazil
  • Middle East & Africa
    • South Africa

Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

SOURCE Grand View Research, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store